Asthma treatment

http://www.healasthma.com . * CUTTING MEDICINE COSTS For many Americans, the rising cost of prescription drugs can be a bitter pill to swallow.Government figures show that prices for all prescription drugs jumped . percent last year — well above the overall inflation rate of . percent.But there are some options available to bring down out-of-pocket drug costs.In recent years, hundreds of companies and organizations have started offering discount prescription drug cards.For a fee, enrollees are promised access to… . Newsday (Melville, NY) – Deaths Spur Asthma-Drug Warning Washington – Twenty users of a new drug for chronic asthma have died since it hit the market in , possibly because they mistakenly tried to use it, rather than a fast-acting inhaler, to relieve an asthma attack.The drug, Serevent, is effective at preventing asthma attacks over a -hour period, and it has been proven safe if used properly, experts said. But it doesn’t treat actual asthma attacks, because it takes at least minutes to begin working…. . Rocky Mountain News OVERUSE OF ASTHMA DRUGS DEADLY HIGH DOSES OF COMMONLY PRESCRIBED REMEDIES CAN TRIGGER FATAL ATTACKS, CANADIAN STUDY INDICATES If you’re one of the million asthmatics in the United States whose lungs seize, wheeze and sputter like an old car, it’s awfully tempting to take extra puffs on your inhaler for quick relief.But that sort of habitual overuse of bronchodilators, the most widely prescribed asthma drugs, carries a stiff health penalty, perhaps even death, according to a soon-to-be published Canadian study that has alarmed doctors, drug makers and, especially, asthma… . Disease Proof – Kids Nebulization Ups Cardiac Injury Risk Jul. , ( Disease Proof delivered by Newstex) Albuterol nebulization often used to treat acute asthma attacks has been shown to increase cardiac risks in children. Via Family Practice News The team speculated that myocardial injury be due to excessive stimulation of β receptors, perhaps in combination with genetic predisposition to myocardial injury associated with that mechanism. “We recommend that children… . (USA) – B RxElite, Inc. Filed Pursuant to Rule (b)( ) Registration No. – PROSPECTUS Subject to Completion , Shares RxElite, Inc.Common Stock This prospectus relates to the resale of up to , , shares of common stock and , , shares of common stock underlying warrants of RxElite, Inc. by certain selling stockholders identified in this prospectus. All of the shares, when sold, will be sold by these selling stockholders. The… . FD (FAIR DISCLOSURE) WIRE – MEDICINOVA INC Conference Call to Discuss Results of MN- Clinical Trial – Final OPERATOR Good day, ladies and gentlemen, and welcome to the MediciNova Conference Call to discuss results of MN- Clinical Trial. My name is Tanya, and I will be your coordinator for today. At this time, all participants are in a listen-only mode. We will conduct a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) As a reminder, this call is being recorded for replay purposes. I would now like to turn the presentation over to Ms. Rhonda… . FD (FAIR DISCLOSURE) WIRE – MEDICINOVA INC Conference Call to Discuss Results of MN- Clinical Trial – Final OPERATOR Good day, ladies and gentlemen, and welcome to the MediciNova Conference Call to discuss results of MN- Clinical Trial. My name is Tanya, and I will be your coordinator for today. At this time, all participants are in a listen-only mode. We will conduct a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) As a reminder, this call is being recorded for replay purposes. I would now like to turn the presentation over to Ms. Rhonda… . FD (FAIR DISCLOSURE) WIRE – MEDICINOVA INC Conference Call to Discuss Results of MN- Clinical Trial – Final OPERATOR Good day, ladies and gentlemen, and welcome to the MediciNova Conference Call to discuss results of MN- Clinical Trial. My name is Tanya, and I will be your coordinator for today. At this time, all participants are in a listen-only mode. We will conduct a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) As a reminder, this call is being recorded for replay purposes. I would now like to turn the presentation over to Ms. Rhonda… . FD (FAIR DISCLOSURE) WIRE – MEDICINOVA INC Conference Call to Discuss Results of MN- Clinical Trial – Final OPERATOR Good day, ladies and gentlemen, and welcome to the MediciNova Conference Call to discuss results of MN- Clinical Trial. My name is Tanya, and I will be your coordinator for today. At this time, all participants are in a listen-only mode. We will conduct a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) As a reminder, this call is being recorded for replay purposes. I would now like to turn the presentation over to Ms. Rhonda… Sepracor Announces Fourth Quarter and Full Year Results Product Revenues Increased by % Over Sepracor Inc. David P. Southwell Chief Financial Officer or Jonae R. Barnes, – - Vice President Investor Relations Sepracor Inc. (Nasdaq SEPR) today announced its consolidated financial results for the fourth quarter and full year .For the three months ended Sepracor’s consolidated revenues were approximately . million, of which revenues from Sepracor’s pharmaceutical… –